DT & Cro Co., Ltd. (383930) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for DT & Cro Co., Ltd. (383930:KRX), powered by AI.

Current Price
₩2,410
P/E Ratio
-11.1
Market Cap
30.8B
Sector
Healthcare
What is the DT & Cro Co., Ltd. stock price forecast?

DT & Cro Co., Ltd. is currently trading at ₩2,410. View real-time AI analysis on Alpha Lenz.

What is DT & Cro Co., Ltd. insider trading activity?

View the latest insider trading data for DT & Cro Co., Ltd. on Alpha Lenz.

What is DT & Cro Co., Ltd.'s P/E ratio?

DT & Cro Co., Ltd.'s P/E ratio is -11.1.

DT & Cro Co., Ltd.

KRX · 383930
₩2,410-40(-1.63%)Market closedKRX regular session 09:00–15:30 KST
Ask about DT & Cro Co., Ltd.'s future dividend policy...
Alpha Chat Insight

DT & Cro Co., Ltd. trades at a P/E of -11.1 (undervalued) with modest ROE of -10.3%.

Ask for details

Company Overview

DT & Cro Co., Ltd. is an engineering and construction firm, primarily engaged in the planning, design, and implementation of construction projects. As a leading player in the industry, the company offers a broad range of services, including civil engineering, urban development, and environmental solutions. DT & Cro Co., Ltd. is instrumental in developing infrastructure that supports urban growth, with a notable impact across various sectors such as transportation, utilities, and real estate. The firm is known for integrating innovative construction technologies and sustainable practices to enhance project efficiency and reduce environmental impact. In the financial market, DT & Cro Co., Ltd. holds significance as it is involved in projects that are often key indicators of economic development and growth potential. By delivering critical infrastructure, the company plays a pivotal role in both domestic and international markets, supporting advancements in living standards and economic resilience.

CEO박채규
SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

₩30,809,748,480Market Cap
₩47,747,299,010Revenue
12.78MShares Out
0Employees

Margins

5.47%Gross
-1.43%EBITDA
-12.03%Operating
-5.19%Pre-Tax
-5.82%Net

Valuation

-11.09P/E
1.23P/B
0.65EV/Sales
-97.24EV/EBITDA
-2.17P/FCF

Growth (CAGR)

2.76%Rev 3Yr
18.90%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-3.24%ROA
-10.33%ROE
-0.21%ROIC

Financial Health

₩335,423,210Cash & Cash Equivalents
₩64,951,246,280Net Debt
260.21%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

DT & Cro Co., Ltd. (ticker: 383930) is a company listed on KRX in the Healthcare sector (Biotechnology). Market cap is $30.8B.

The current price is ₩2,410 with a P/E ratio of -11.09x and P/B of 1.23x.

ROE is -10.33% and operating margin is -12.03%. Annual revenue is $47.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
DT & Cro Co., Ltd. (383930) Stock Forecast 2026 ₩2,410 — Price, Financials & Analyst Targets | Alpha Lenz